Editorial: Insights in Inflammation Pharmacology: 2021

Bibliographic Details
Main Authors: Paola Patrignani, Dieter Steinhilber
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.928535/full
_version_ 1811233505505443840
author Paola Patrignani
Dieter Steinhilber
author_facet Paola Patrignani
Dieter Steinhilber
author_sort Paola Patrignani
collection DOAJ
first_indexed 2024-04-12T11:21:10Z
format Article
id doaj.art-8310f4a65045403baef1ce9ee4d356b5
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T11:21:10Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-8310f4a65045403baef1ce9ee4d356b52022-12-22T03:35:22ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-05-011310.3389/fphar.2022.928535928535Editorial: Insights in Inflammation Pharmacology: 2021Paola Patrignani0Dieter Steinhilber1Department of Neuroscience, Imaging and Clinical Science, and CAST, “G. d’Annunzio” University, Chieti, ItalyInstitut fuer Pharmazeutische Chemie, Universitaet Frankfurt, Frankfurt am Main, Germanyhttps://www.frontiersin.org/articles/10.3389/fphar.2022.928535/fullinflammatioinresolutionfibrosisanaphyalaxis5-lipoxygenasecyclooxygenase-2
spellingShingle Paola Patrignani
Dieter Steinhilber
Editorial: Insights in Inflammation Pharmacology: 2021
Frontiers in Pharmacology
inflammatioin
resolution
fibrosis
anaphyalaxis
5-lipoxygenase
cyclooxygenase-2
title Editorial: Insights in Inflammation Pharmacology: 2021
title_full Editorial: Insights in Inflammation Pharmacology: 2021
title_fullStr Editorial: Insights in Inflammation Pharmacology: 2021
title_full_unstemmed Editorial: Insights in Inflammation Pharmacology: 2021
title_short Editorial: Insights in Inflammation Pharmacology: 2021
title_sort editorial insights in inflammation pharmacology 2021
topic inflammatioin
resolution
fibrosis
anaphyalaxis
5-lipoxygenase
cyclooxygenase-2
url https://www.frontiersin.org/articles/10.3389/fphar.2022.928535/full
work_keys_str_mv AT paolapatrignani editorialinsightsininflammationpharmacology2021
AT dietersteinhilber editorialinsightsininflammationpharmacology2021